<DOC>
	<DOCNO>NCT00735566</DOCNO>
	<brief_summary>Endogenous antiangiogenic factor related gastric cancer progression .</brief_summary>
	<brief_title>Antiangiogenic Factors Gastric Cancer</brief_title>
	<detailed_description>Gastric cancer know secrete proangiogenic cytokine VEGF vitro vivo . Tumor VEGF expression correlate severity disease patient gastric cancer author suggest use circulate VEGF prognostic factor tumor marker.In addition produce proangiogenic cytokine , recent data demonstrate tumor produce antiangiogenic cytokine well . It suggest , human , generation antiangiogenic compound presence primary tumor suppress growth distant metastasis . This phenomenon demonstrate mice patient clear cell renal cancer , breast cancer , colorectal cancer . However , presence endogenous antiangiogenic cytokine patient gastric cancer report .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Angiogenesis Inhibitors</mesh_term>
	<criteria>Histologic diagnosis gastric adenocarcinoma No form cancer therapy , chemotherapy radiotherapy least 3 week enrollment study Performance status 0 , 1 , 2 ECOG criterion ASA class I , II Patient compliance allow adequate follow Informed consent patient patient 's relative . Second primary malignancy EMR ( Endoscopic mucosal resection ) indication Laparoscopic gastrectomy Radiologic clinical evidence metastasis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>gastric cancer</keyword>
	<keyword>antiangiogenic factor</keyword>
	<keyword>TNM stage</keyword>
</DOC>